Behavioral Family Therapy and Type One Diabetes
Status: | Recruiting |
---|---|
Conditions: | Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 2 - 17 |
Updated: | 10/27/2018 |
Start Date: | October 22, 2018 |
End Date: | June 30, 2021 |
Effect of Behavioral Family Therapy on Glycemic Control in Children With Type One Diabetes
Behavioral family therapy, specifically focused on insuring support for the primary caregiver
of a child with type one diabetes mellitus and healthy family dynamics, may improve the
child's glycemic control as measured by hemoglobin A1c level (HbA1c).
of a child with type one diabetes mellitus and healthy family dynamics, may improve the
child's glycemic control as measured by hemoglobin A1c level (HbA1c).
The success or failure of type 1 diabetes mellitus (T1D) management in children depends not
only on access to care, diabetes technologies and diabetes education, but also on the
abilities of the patient and his/her family to carry out complex demands. Recent data show
that family dynamics play a critical role in determining glycemic control in pediatric
patients with T1D. The investigators prior work (Loomba-Albrecht and Glaser, unpublished
data) suggests that the strongest determinants of glycemic control are factors related to the
primary caregiver's involvement in supportive relationships with others, either a spouse or
other family members. This provides a potential therapeutic target to improve outcomes for
children with T1D.
only on access to care, diabetes technologies and diabetes education, but also on the
abilities of the patient and his/her family to carry out complex demands. Recent data show
that family dynamics play a critical role in determining glycemic control in pediatric
patients with T1D. The investigators prior work (Loomba-Albrecht and Glaser, unpublished
data) suggests that the strongest determinants of glycemic control are factors related to the
primary caregiver's involvement in supportive relationships with others, either a spouse or
other family members. This provides a potential therapeutic target to improve outcomes for
children with T1D.
Inclusion Criteria:
Aim 1: Eligibility and exclusion criteria:
Eligible patients will be recruited through the UC Davis pediatric endocrinology clinic or
during their initial admission (if they plan to seek care at our clinic) and must meet the
following criteria:
- age 2 to 17 years
- newly diagnosed (within the past 10 weeks) with T1D
- child lives in a two parent household
Aim 2: Eligibility and exclusion criteria:
Eligible patients will be recruited through the UC Davispediatric endocrinology clinic and
must meet the following criteria:
- age 2 to 17 years
- diagnosed with T1D with a duration of diabetes of at least 2 years (to ensure the
child is no longer producing endogenous insulin)
- using a "multiple daily injection" or "basal-bolus" insulin regimen (includes pump
users)
- HbA1c level of 9% or higher at enrollment visit
- child lives in a two parent household
Exclusion Criteria:
- Families will be excluded if the child has severe underlying psychiatric, behavioral
or medical conditions which could independently affect parental marital stress
We found this trial at
1
site
1 Shields Ave
Sacramento, California 95616
Sacramento, California 95616
(530) 752-1011
Phone: 916-734-4729
University of California-Davis As we begin our second century, UC Davis is poised to become...
Click here to add this to my saved trials